AI, IP Valuation, & Biotech

As previously discussed in this blog post, Artificial Intelligence has made leaps and bounds in its capabilities over the past decade, to the point that this once novel technology has become an integral part of any biotechnology company. With differentiation in AI itself dwindling, industries are being rebuilt around the application of AI. One such prominent space is biotechnology, which today is amongst the largest global industries at an estimated value of $753B. It is expected to grow to nearly $2.5T by 2028. To keep up with this growth, new AI companies and products are being created to uncover the most relevant data points from this enormous data haystack.